Revenue Update on Teladoc Inc(NYSE:TDOC)

Teladoc Inc(NYSE:TDOC) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 3, 2016. Company reported revenue of $26.49M. Analysts estimated a revenue of $28.20M. Earnings per share were $-0.38. Analysts had estimated an EPS of $-0.40.

In a different note, Piper Jaffray said it Initiates Coverage on Teladoc Inc, according to a research note issued on May 26, 2016. The shares have been rated ‘Overweight’ by the firm.

Teladoc Inc (TDOC) made into the market gainers list on Fridays trading session with the shares advancing 1.86% or 0.32 points. Due to strong positive momentum, the stock ended at $17.56, which is also near the day’s high of $17.82. The stock began the session at $17.3 and the volume stood at 2,90,338 shares. The 52-week high of the shares is $31 and the 52 week low is $9.08. The company has a current market capitalization of $803 M and it has 4,57,05,392 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On Jul 15, 2016, Jason N Gorevic (President & CEO) sold 5,000 shares at $15.45 per share price.Also, On Jul 1, 2016, James K Outland (director) sold 10,000 shares at $15.00 per share price.On Mar 18, 2016, Dana G Jr. Mead (director) purchased 10,000 shares at $10.65 per share price, according to the Form-4 filing with the securities and exchange commission.

Teladoc Inc. is a telehealth company. The Company offers an on-demand healthcare platform through mobile devices Internet video and phone. Its solution connects consumers with physicians and behavioral health professionals or its providers who treat various conditions and cases from acute diagnoses such as upper respiratory infection urinary tract infection and sinusitis to dermatological conditions anxiety and smoking cessation. The Teladoc solution enables accessing on-demand healthcare for employers health plans and health systems. Its platform provides accessing physicians clinical programs and consumer engagement strategies. Its platform provides for interconnectivity between healthcare constituents. It offers solutions such as remote patient monitoring post-discharge treatment plan adherence and in-home and chronic care. Its customers also include channel partners such as brokers resellers and consultants who sell into a range of small medium and large enterprises.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Teladoc Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Teladoc Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.